GORDON CARL L
- SEC CIK
- 0001282930
Latest role at each company
- ETRA Electra Therapeutics, Inc.Director, 10% Owneras of Sep 23, 2026
- BLSM BlossomHill Therapeutics, Inc.Directoras of Aug 12, 2026
- SCTX Scribe Therapeutics, Inc.Directoras of Jul 29, 2026
- CMPX Compass Therapeutics, Inc.Directoras of Jan 5, 2026
- KROS Keros Therapeutics, Inc.Directoras of Dec 18, 2025
Show 9 more companies
- MBX MBX Biosciences, Inc.Director, 10% Owneras of Feb 19, 2025
- CIK 0001900520Directoras of Nov 5, 2024
- ACET Adicet Bio, Inc.Director, 10% Owneras of Aug 23, 2024
- CIK 0001831363Director, 10% Owneras of Jul 17, 2024
- HLSQ Tessera Defense & Homeland Security Inc.10% Owneras of May 20, 2024
- CIK 0001797768Director, 10% Owneras of Apr 5, 2024
- CIK 0001745020Director, 10% Owneras of Feb 14, 2024
- AVBP ArriVent BioPharma, Inc.Director, 10% Owneras of Jan 31, 2024
- IRON Disc Medicine, Inc.Director, 10% Owneras of Oct 6, 2021
Trades
Every Form 4 that lists GORDON CARL L as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| ETRAElectra Therapeutics, Inc. | Sep 23, 20265:35 PM ET | Sep 21, 2026 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +1.33M | $15.00 | +$20.0M | 1.76M | +313.8% | SEC |
| BLSMBlossomHill Therapeutics, Inc. | Aug 12, 20264:46 PM ET | Aug 10, 2026 | GORDON CARL LDirector | PPurchaseCommon Stock | +625.0K | $16.00 | +$10.0M | 2.71M | +29.9% | SEC |
| SCTXScribe Therapeutics, Inc. | Jul 29, 20266:50 PM ET | Jul 27, 2026 | GORDON CARL LDirector | PPurchaseCommon Stock | +1.00M | $15.00 | +$15.0M | 1.35M | +286.7% | SEC |
| CMPXCompass Therapeutics, Inc. | Apr 11, 2025 | Apr 9, 2025 | GORDON CARL LDirector, 10% Owner | SSaleCommon Stock | −3.57M | $1.59 | −$5.68M | 0 | −100.0% | SEC |
| MBXMBX Biosciences, Inc. | Feb 19, 2025 | Feb 14 – Feb 18, 2025 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +190.7K | $10.5981 | +$2.02M | 747.9K | +34.2% | SEC |
| MBXMBX Biosciences, Inc. | Sep 17, 2024 | Sep 16, 2024 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +750.0K | $16.00 | +$12.0M | 653.8K | New position | SEC |
| KROSKeros Therapeutics, Inc. | Aug 15, 2024 | Aug 13, 2024 | GORDON CARL LDirector | SSaleCommon Stock | −250.0K | $44.01 | −$11.0M | 119.5K | −67.7% | SEC |
| – | Jul 17, 2024 | Jul 15 – Jul 16, 2024 | GORDON CARL LDirector, 10% Owner | SSaleCommon Stock | −56.2K | $10.00 | −$561.6K | 755.6K | −6.9% | SEC10b5-1 |
| HLSQTessera Defense & Homeland Security Inc. | May 20, 20244:39 PM ET | May 15, 2024 | GORDON CARL L and 3 others10% Owner | SSaleCommon Stock | −24.3K | $0.3812 | −$9.28K | 13.8M | −0.2% | SEC |
| HLSQTessera Defense & Homeland Security Inc. | Mar 19, 20249:06 PM ET | Mar 15, 2024 | GORDON CARL L and 3 others10% Owner | PPurchaseCommon Stock · Derivative | +6.49M | – | – | 2.16M | – | SEC |
| AVBPArriVent BioPharma, Inc. | Jan 31, 2024 | Jan 30, 2024 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +444.4K | $18.00 | +$8.00M | 1.51M | +41.6% | SEC |
| ACETAdicet Bio, Inc. | Jan 26, 2024 | Jan 25, 2024 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +3.13M | $2.40 | +$7.50M | 1.26M | New position | SEC |
| – | Jul 19, 2023 | Jul 17, 2023 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +479.9K | $3.05 | +$1.46M | 650.6K | +281.2% | SEC |
| ACETAdicet Bio, Inc. | Jun 29, 2023 | Jun 27, 2023 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +875.0K | $2.09 | +$1.83M | 748.1K | New position | SEC |
| – | May 8, 2023 | May 4 – May 5, 2023 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +1.46M | $2.797 | +$4.09M | 1.37M | New position | SEC |
| – | May 2, 2023 | Apr 28 – May 2, 2023 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +1.41M | $2.6146 | +$3.67M | 794.4K | New position | SEC |
| HLSQTessera Defense & Homeland Security Inc. | Mar 17, 20234:29 PM ET | Feb 27, 2023 | GORDON CARL L and 3 others10% Owner | PPurchaseCommon Stock | +348.0K | $0.245 | +$85.3K | 3.16M | +12.4% | SEC |
| HLSQTessera Defense & Homeland Security Inc. | Mar 17, 20234:29 PM ET | Feb 27, 2023 | GORDON CARL L and 3 others10% Owner | PPurchaseCommon Stock · Derivative | +1.79M | – | – | 1.79M | – | SEC |
| – | Dec 28, 2022 | Dec 23, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +137.9K | $7.25 | +$1.00M | 4.88M | +2.9% | SEC |
| CMPXCompass Therapeutics, Inc. | Nov 10, 2022 | Nov 8, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +402.0K | $3.21 | +$1.29M | 15.2M | +2.7% | SEC |
| – | Nov 9, 2022 | Nov 7, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +192.0K | $5.21 | +$1.00M | 16.7M | +1.2% | SEC |
| – | Aug 18, 2022 | Aug 16, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +3.69M | $2.42 | +$8.93M | 762.4K | New position | SEC |
| – | Aug 18, 2022 | Aug 16, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock · Derivative | +310.0K | – | – | 64.0K | – | SEC |
| CMPXCompass Therapeutics, Inc. | May 13, 2022 | May 11 – May 13, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +192.5K | $2.1841 | +$420.5K | 14.8M | +1.3% | SEC |
| CMPXCompass Therapeutics, Inc. | May 10, 2022 | May 6 – May 10, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +125.4K | $1.5735 | +$197.3K | 14.6M | +0.9% | SEC |
| – | Feb 15, 2022 | Feb 11 – Feb 15, 2022 | GORDON CARL LDirector | PPurchaseCommon Stock | +195.7K | $10.1658 | +$1.99M | 3.51M | +5.9% | SEC |
| – | Jan 21, 2022 | Jan 19 – Jan 21, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +158.4K | $9.9656 | +$1.58M | 16.5M | +1.0% | SEC |
| – | Jan 13, 2022 | Jan 11 – Jan 13, 2022 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +44.7K | $9.9012 | +$442.8K | 16.4M | +0.3% | SEC |
| CMPXCompass Therapeutics, Inc. | Nov 8, 2021 | Nov 4, 2021 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +5.36M | $3.50 | +$18.8M | 3.57M | New position | SEC |
| – | Oct 14, 2021 | Oct 12, 2021 | GORDON CARL LDirector, 10% Owner | PPurchaseCommon Stock | +625.0K | $16.00 | +$10.0M | 499.1K | New position | SEC |